Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck

Clinical Nuclear Medicine

Volumn 35, Issue 10, 2010, Pages 800-801

  Salem, Shahenda ^a   Patel, Neva H ^b   Barwick, Tara ^c   Al Nahhas, Adil ^c   Howard, David J ^b   Zerizer, Imene ^c   Win, Zarni ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

carcinoma of unknown primary; F 18 FDG PET CT; head neck tumors

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CASE REPORT; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LYMPHADENOPATHY; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE UVULA; TUMOR BIOPSY;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MOUTH NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; UVULA;

EID: 77957361098     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181ef09cb     Document Type: Article

References (9)

1. Carvalho AL, Nishimoto IN, Califano JA, et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114:806-816.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
3. Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev. 2004;30:153-164.
4. Weber RS, Peter LJ, Wolf P, et al. Squamous cell carcinoma of the soft palate, uvula, and anterior faucial pillar. Otolaryngol Head Neck surg. 1988;99:16-23.
5. Huk S, Harrison LB, Culliney, et al. Cancer of the oropharynx. In: Harrison LB, sessions RB, Hong WK, eds. Head and Neck Cancer: A Multidisciplinary Approach. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004: 306-351.
6. Hanasono MM, Kunda LD, Segall GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope. 1999;109:880-885.
7. Safa AA, Tran LM, Rege S, et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am. 1999;5:214-218.
8. Greven KM, Keyes JW Jr, Williams DW III, et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18] fluoro-2-deoxy-D-glucose. Cancer. 1999;86:114-118.
9. Kapoor V, Fukui MB, McCook BM. Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. Am J Roentgenol. 2005;184:579-587.